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The amino acid sequence of the proteolipid subunit of the A TP synthase was analyzed in six 
mutant strains from Escherichia coli K 12, selected for their increased resistance towards the inhibitor 
N,N'-dicyclohexylcarbodiimide. All six inhibitor-resistant mutants were found to be altered at the 
same position of the proteolipid, namely at the isoleucine at residue 28. Two substitutions could be 
identified. In type I this residue was substituted by a valine resulting in a moderate decrease in 
sensitivity to dicyclohexylcarbodiimide. Type II contained a threonine residue at this position. Here 
a strong resistance was observed. 
These two amino acid substitutions did not influence functional properties of the ATPase 
complex. ATPase as well as A TP-dependent proton-translocating activities of mutant membranes 
were indistinguishable from the wild type. At elevated concentrations, dicyclohexylcarbodiimide 
still bound specifically to the aspartic acid at residue 61 of the mutant proteolipid as in the wild type, 
and thereby inhibited the activity of the ATPase complex. 
It is suggested that the residue 28 substituted in the resistant mutants interacts with dicyclo-
hexylcarbodiimide during the reactions leading to the covalent attachment of the inhibitor to the 
aspartic acid at residue 61. This could indicate that these two residues are in close vicinity and 
would thus provide a first hint on the functional conformation of the proteolipid. Its polypeptide 
chain would have to fold back to bring together these two residues separated by a segment of 
32 residues. 
A TP synthases isolated from prokaryotic and 
eukaryotic organisms generally contain a proteolipid 
subunit constituting the major component of the ATP 
synthase membrane factor, Fo [1 - 5]. This low-molec-
ular-weight subunit is the target of the inhibitor di-
cyclohexylcarbodiimide which blocks the enzymatic 
activity of the whole complex by inhibition of the 
proton-translocating activity of the membrane factor, 
Fo [6 - 9]. Proton-translocating properties have been 
attributed to this proteolipid subunit [10,11]. 
The amino acid sequence of the proteolipid from a 
variety of sources has been determined including 
mitochondria (Neurospora crassa, Saccharomyces ce-
revisiae, beef heart), chloroplasts (spinach), and bac-
teria (Escherichia coli, PS-3) [12-14]. A comparison 
of these evolutionary distant but homologous se-
Ahhreviutions. (cHxN)zC, N,N-dicycIohexylcarbodiimide; 
Mops, 4-morpholinepropanesulfonic acid. 
Enzyme. ATPase or A TP phosphohydrolase or A TP synthase 
(EC 3.6.1.3). 
quences allows the identification of typical features 
as well as of invariant, i.e. functionally important, 
residues of this ATPase subunit. 
An acidic position which occurs in the middle of 
a hydrophobic segment appears to be of special im-
portance. It is the only acidic residue which is con-
served in all organisms. Furthermore, this group is 
specifically and covalently modified by the inhibitor 
dicyclohexylcarbodiimide [15]. Recently, an ATPase 
mutant from E. coli has been described whose mem-
brane factor is unable to translocate protons. Here 
this acidic residue is exchanged for a glycine [16]. 
Mutants containing a dicyclohexylcarbodiimide-
resistant ATP synthase have been isolated in E. coli 
[17,18]. By genetic analysis the resistance mutation 
was shown to be located in the unc-gene region. At 
concentrations effective in the wild type, the carbo-
diimide does not inhibit the mutant enzyme, and does 
not bind covalently to the proteolipid subunit. The 
present analysis of six inhibitor-resistant strains showed 
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single amino acid substitutions in the proteolipid. The 
carbodiimide-reactive aspartyl residue of this protein, 
however, was found to be unaffected. It is proposed 
that the residue of the proteolipid altered in the 
resistant strains is involved in the noncovalent binding 
of dicyclohexylcarbodiimide which has to proceed the 
covalent reaction of the carbodiimide with the aspartyl 
residue. Other explanations appear to be unlikely 
since the amino acid substitutions are inconspicuous 
(isoleucine/valine; isoleucine/threonine) and since 
functional properties of the mutant A TP synthase are 
undisturbed according to several criteria. 
MATERIALS AND METHODS 
Carboxymethylcellulose, CM-52, was purchased 
from Whatman. Bio-Gel P-30, minus-400 mesh (con-
trol number 106044), was obtained from BioRad 
Laboratories. 3-Aminopropyl-glass and p-N-amino-
ethyl (3-aminopropyl)-glass were prepared as described 
[19]. P4C]Dicyclohexylcarbodiimide was synthesized 
from [14C]urea (Amersham Buchler) (55 Ci/mol) via 
dicyclohexylurea [20,21]. Pyridine, N-methylmorpho-
line, N,N'-dimethylformamide, and triethylamine were 
distilled over ninhydrin. Trifluoroacetic acid was dis-
tilled over 96 % sulfuric acid, and then mixed with 
0.1 % (v/v) water. S-Amino-6-chloro-2-methoxyacri-
dine was a gift from Dr P. Overath (MPI for Biology, 
Tilbingen). All other chemicals were of highest avail-
able purity. 
Bacterial Strains 
Strain A (lac!, fadR, but12, rha) is derived from 
Escherichia coli K12 Y mel (}.) F-. Mutants with an in-
creased resistance towards dicyclohexylcarbodiimide 
were isolated as described [lS]. The inhibitor proper-
ties of the dicyclohexylcarbodiimide on the ATPase 
activity of the resulting strains were tested. Mutants 
with an increased resistance were subjected to PI 
transduction into strain DG 20/1 (uncA-, ilv-, met-). 
Transduction was performed according to Lennox 
[22]. Five strains with an altered resistance were ob-
tained: DC13, DC19, DC24, DC25, DC54. 
Growth of Cells 
Cells were grown in CR medium with 1 % glucose 
as the carbon source. For the mutants 0.1 mg/ml 
methionine was included. Cells were cultivated in 
500-1 fermenters until late log phase. Typically 5 kg 
cells (wet weight) were obtained. 
Preparation of the Proteolipid Subunit 
The cells were incubated with lysozyme (1 mg/g 
wet weight) and DNase (20 J.!g/g wet weight) for 3 h 
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at 30°C. Then a crude membrane fraction was sedi-
mented at SOOO x g for 15 min. The ATPase proteo-
lipid was isolated by extraction of the crude mem-
brane fraction with chloroform/methanol (2: 1, v/v) 
[S] and subsequent chromatography on carboxymethyl-
cellulose in mixtures of chloroform/methanol/water. 
The pure E. coli proteolipid was eluted from the 
column during the wash with chloroform/methanol/ 
water(5:5:1, v/v/v) [16,23]. The purity of the isolated 
proteins was checked by sodium dodecylsulfate elec-
trophoresis [14] and Bio-Gel P-30 chromatography in 
the presence of SO % formic acid. Lipid content as 
determined by the measurement of organic phos-
phorous content [24] is less than 1 J.!g/mg protein. 
Typical yields are 2 - 3 mg of pure protein from 100 g 
of cells (wet weight). 
Labelling with Dicyclohexylcarbodiimide 
2 g (wet weight) fresh cells (log phase) were sus-
pended in 10 ml buffer (50 mM Mops pH 7.0, 10 mM 
MgCb, 175 mM KCI, 0.2 mM dithiothreitol, 0.2 mM 
phenylmethylsulfonyl fluoride, 20 mM benzamidine). 
The cells were broken by a passage through a Ribi-
press at lS000 Ib x in -2 (124 MPa) at 10-15 nc. After 
reducing the viscosity by incubation with DNase and 
removal of the cell debris by centrifugation at 20000 xg 
for 20 min, membranes were sedimented for 1 h at 
235000 xg. The membrane pellet was suspended with 
buffer (50 mM Tris pH S.O, 10 mM MgC\z, 175 mM 
KC1, 0.2 mM dithiothreitol, 0.2 mM phenylmethyl-
sulfonyl fluoride, 20 mM benzamidine) at a protein 
concentration of about 10 mg/m!. For reaction with 
dicyclohexylcarbodiimide the protein concentration 
was adjusted to 1 mg/ml with the same buffer. Dicyclo-
hexylcarbodiimide was added in 2 J.!l ethanol. Incuba-
tion was carried out overnight at 0 QC. Labelling with 
[14C]dicyclohexylcarbodiimide was performed at 5 mg 
protein per ml under the same conditions. Aliquots 
of 30 J.!l were used for measurement of the ATPase 
activity [1S] and the energy-dependent quenching of 
9-amino-6-chloro-2-methoxyacridine fluorescence [1, 
lS]. One unit of ATPase activity is defined as the 
amount of enzyme which catalyzed the hydrolysis of 
1 J.!mol of ATP per min at 30 DC and pH S. 
The initial rate of fluorescence quenching was 
extrapolated to 1 min and expressed as units of fluo-
rescence-quenching activity. 1 unit of fluorescence-
quenching activity is defined as the amount of mem-
brane which quenches the fluorescence of the acridine 
dye with an initial rate of 100 % in 1 min [1]. 
Analytical Procedures 
Protein concentration was determined by the 
method of Lowry [25] using bovine serum albumin as 
the standard. Since the method of Lowry leads to an 
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underestimation of the protein content [8], in several 
cases amino acid analysis was used instead. 14C-radio-
activities were measured in a Packard PRIAS liquid 
scintillation spectrometer. All samples were first dis-
solved in 0.5 ml buffer (1 % sodium dodecylsulfate, 
0.1 M Tris acetate pH 8.0) and then 3 ml of Emulsifier 
(Packard) were added. 
Chemical Cleavage and Fractionation of Pep tides 
Cleavage with CNBr and subsequent chromatog-
raphy on Bio-Gel P-30 was performed as described [14]. 
N-terminal amino acid residues were determined 
by the dansylation method [26]. The N-terminal formyl 
group [27] was removed by a 4-h incubation in 0.5 M 
HCl dissolved in dry methanol at room temperature. 
Amino acid analysis was performed with an auto-
mated amino acid analyzer (Biotronic LC 2000). Me-
thionine was determined as methionine sulfone after 
performic acid oxidation [28]. 
Thin-layer chromatography of the peptides was 
performed as described [16]. 
Automated Solid-Phase Edman Degradation 
The whole proteolipid was immobilized by cou-
pling its carboxyl group(s) to 3-aminopropyl-glass. 
The proteins (2 - 4 mg) dissolved in 2 - 5 ml chloro-
form/methanol/water (5: 5: 1) were shaken with 175 mg 
aminated glass (equilibrated with 1 M pyridine/HCl 
pH 5.5) in the presence of 8 mg dicyclohexylcarbo-
diimide and 4 mg N-hydroxysuccinimide. Coupling 
yields were nearly quantitative. The large cyanogen-
bromide fragments B6 were attached to fi-N-amino-
ethyl(3-aminopropyl)-glas using the homo serine lac-
tone procedure [29]. As these fragments are insoluble 
in pure N,N'-dimethylformamide they were first dis-
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solved in 10 J.tl trifluoroacetic acid. 500 J.tl N,N'-di-
methylformamide were then added yielding a clear 
solution. 170 mg aminated glass and 100 J.tl triethyl-
amine were then added. The mixture was incubated 
for 6 h at 65°C. The loaded glass beads were washed 
twice with 1 ml trifluoroacetic acid, then with methanol 
and diethylether and dried. Coupling yield ranged 
from 20 to 40 %. Sequencing and analysis of the 
phenylthiohydantoin were performed as described 
[14,16]. The initial yield of the phenylthiohydantoin 
cleaved off was about 40 % of the amount attached to 
the glass beads. 
RESULTS 
Sensitivity of the Mutant ATP Synthase 
towards Dicyclohexylcarbodiimide 
Fig. 1 A shows the inhibition of the membrane-
bound ATPase activity at various inhibitor concentra-
tions. For the wild type half-maximal inhibition was 
found at 3 - 5 nmol inhibitor/mg protein, and com-
plete inactivation occurred at amounts higher than 
20 nmol/mg protein. With the mutant, two classes 
can be distinguished. Class one, consisting of mutants 
DC13, DC19, DC24, shows 50 % inhibition at 30 nmol 
inhibitor /mg protein. The ATPase activity is maximally 
inhibited at concentrations higher than 160 nmol/mg 
protein. Class-two mutants (DC25, DC54) exhibit 
higher resistance. Half-maximal inhibition is achieved 
at 200 nmol inhibitor/mg protein. 
A more specific test for the functional A TP syn-
thase complex is provided by the measurement of the 
ATP-dependent proton translocation. Fig. 1 B shows 
the inhibition of the initial rate of ATP-dependent 
acridine-dye fluorescence quenching in inside-out 
membrane vesicles. It has been shown that the initial 
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Fig. 1. Inhihition of the A TPase activity and the energy-dependent quenching of the acridine-dye fluorescence. Wild-type and mutant membrane 
preparations were incubated with the indicated amount of dicydohexylcarbodiimide (see Materials and Methods). 30 ~l of the incubation 
mixture were used for the determination of the following. (A) Inhibition of the ATPase activity; (D) wild type; (t,) DC13; (0) DC19; 
(e) DC24; (D) DC25; (0) DC54. (B) Inhibition of the energy-dependent quenching of the fluorescence of 9-amino-6-chloro-2-methoxy-
acridine. The reaction mixture (1 ml total volume) contained 2 ~M 9-amino-6-chloro-2-methoxyacridine, 1 ~M valinomycin, 25 mM 
Mops, 0.3 M KCl, 10 mM MgCb pH 7.3. The reaction was started by the addition of 10 ~l 0.2 M ATP solution 
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rate is proportional to rate of proton translocation [30]. 
Again the high and the low resistance class of mutants 
can be distinguished by their response to increasing 
inhibitor concentrations. The values required for 50 % 
inhibition are comparable to that obtained by the 
A TPase activity measurements. The ATP-dependent 
proton translocation, however, could be inhibited 
completely in the case of the wild type and the class-
one mutant membrane. 
Unaltered Functional Properties 
of the A TP Synthase in the Mutant Strains 
A TPase activities for the wild-type ATPase and 
mutant ATPase ranged from 1.7 to 2.0 U /mg. As a 
second criterion for the functional integrity of A TP 
synthase of the mutants, A TP-dependent H + trans-
location was determined by the initial rates of energy-
dependent acridine-dye fluorescence quenching. Values 
ranged from 14 to 18 fluorescence-quenching units/mg 
[1]. Again no detectable differences between wild type 
and mutants could be found. 
According to these two sets of experiments the 
function of the mutant A TP synthases is not appar-
ently influenced by the mutation leading to an in-
creased resistance towards dicyclohexylcarbodiimide. 
Binding of [ 14C ] Dicyclohexylcarhodiimide 
to Mutant Proteolipid 
As demonstrated in the first paragraph, dicyclo-
hexylcarbodiimide at higher concentrations still in-
hibits A TP synthase activity of the mutant strains. 
Considering the unspecific binding of the inhibitor 
to many polypeptides in the E. coli membrane [8], it 
was important to examine whether or not in the 
mutant membranes the specificity of binding is re-
tained at the level of the A TP synthase and the proteo-
lipid subunit at increased inhibitor concentrations. 
Conditions under which the mutants' ATP synthase 
is maximally inhibited would require very high con-
centrations of radioactive dicyclohexylcarbodiimide. 
Therefore, the analysis was restricted to lower con-
centrations. Table 1 shows the reactivity of mutant 
proteolipid representative for class one and two at 
5 nmol 14C-labelled inhibitor/mg membrane protein, 
which concentration is highly effective for the wild 
type. In addition, the effect of a fourfold higher amount 
of e4C](cHxNhC was investigated for the mutant 
membranes. With the wild type, at 85 % inhibition 
of proton translocating activity, 0.2 mol of e4C]-
(cHxN)zC were bound/mol of the isolated proteolipid. 
This value correlates with earlier reports that at 
maximal inhibition of the ATPase activity one third 
of the proteolipid oligomer is modified by the inhibi-
tor [8]. At an inhibitor concentration of 5 nmol/mg 
of protein, the mutant proteins only bound 0.07 and 
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Table 1. Reactivitv of the mutant protein towards dicyc/ohexy/-
carbodiimide 
Membranes (30 mg protein) were labelled with [t4C]dicyclohexyl-
carbodiimide. The dicyclohexylcarbodiimide-binding proteins were 
purified in microscale as described under Materials and Methods. 
The protein content is based on amino acid analysis. The values in 
parenthesis represent the percentage of the inhibition of H + trans-
location activities. n.d., not determined 
Strains 
Al (wild type) 
DCI3 (class one) 
DC25 (class two) 
Proteolipid-bound 
[14C](cHxNhC at 
5 nmol/kg 
mol/mol 
0.2 (85) 
0.07 (34) 
0.05 (10) 
22 nmol/mg 
n.d. 
0.11 
0.078 
0.05 mol/mol, respectively, resulting in a 34 % and 
10% inhibition. The amount of proteolipid-bound 
inhibitor is roughly proportional to the inhibition of 
the proton-translocating activity. At the 4.4-fold higher 
concentration of inhibitor during incubation a slight 
increase in proteolipid-bound e4C](cHxN)zC was ob-
tained as expected from the dose-inhibition curves 
shown in Fig. 1 B. These results are in agreement with 
the idea that also in the inhibitor-resistant mutants 
the (cHxNhC is still bound to the proteolipid albeit 
to a much lower extent. This low residual binding 
correlates with the low inhibition. 
The specificity of the [14C](cHxN)zC binding in 
mutant proteolipid was examined by sequence anal-
ysis. Earlier studies have shown that in the wild type 
the bound carbodiimide radioactivity is recovered 
exclusively with the aspartic acid at position 61 of 
the polypeptide chain [13]. After CNBr cleavage at 
the eight methionine residues of the proteolipid, this 
carbodiimide-reactive aspartyl residue occurs at posi-
tion 4 of cyanogen bromide fragment B7 (residues 
58 - 65) (see Fig.4). [14C](cHxN)zC-Iabelled proteo-
lipid from mutant DC13 (class one) and DC25 (class 
two) were cleaved with CNBr, and the resulting frag-
ments separated on a Bio-Gel P-30 column as shown 
in Fig. 2 B for mutant DCn As a control, labelled 
wild-type proteolipid was analysed in parallel (Fig. 2A). 
Radioactivity was eluted in three peaks, occurring in 
the same fractions and the same proportions with 
both proteolipids. The first peak corresponds to un-
cleaved proteolipid and the second to the partial 
fragment of B7 plus B8 (E. Wachter, unpublished 
results). The third peak contains about 80 % of the 
total 14C-radioactivity, and is eluted together with a 
mixture of peptides B7 and B8 (see also Fig. 3). 
During sequence analysis of this fraction (insert of 
Fig.2A, B) the [14C](cHxN)zC radioactivity is re-
covered at position 4 in both the mutant DC13 and 
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Fig.2. P30 gel chromatography of' cyanogen-hromide fragments of'the dicyc/ohexylcarbodiimide-binding proteins and determination of'the 
residue. Memhranes were lahelled with [t4C]dicyclohexylcarbodiimide at a concentration of 22 nmol/mg of memhrane protein. The isolated 
proteolipid was cleaved with CNBr. Fractions obtained after P30 gel chromatography (0.4 x 150 cm) were analyzed for t4C-radioactivity. 
Fractions of 150 ~I were collected, (A) Wild type (0.2 mg); (, , ... ) refractive index; (e--e) t4C-radioactivity. (B) Mutant DC13 (0.05 mg). 
Insert: for determination of the [t4C]dicyclohexylcarbodiimide-binding residue fractions containing the peptide B7 (shaded peak) were 
collected. The peptides were coupled by the homoserine-Iactone method to Ii-N-aminoethyl(3-aminopropyl)-glass and subjected to auto-
matic Edman degradation. Aliquots of the released phenylthiohydantoin derivatives were analyzed for t4C-radioactivity 
the wild type. Comparable results were obtained with 
class-two mutant DC25. Thus, the specificity of di-
cyclohexylcarbodiimide- binding is retained in the 
proteolipid from inhibitor-resistant mutants. 
Identification of Amino Acid Suhstifutions 
in the Mutant Proteolipid,I' 
The A TP synthase proteolipid was purified from 
the (cHxN)zC-resistant strains described in the previ-
ous paragraphs as well as from mutant DCl partially 
characterized in an earlier publication [18]. 
Amino acid analysis of the whole proteins is shown 
in Table 2. Clearly one extra threonine is recognized 
in mutants DC25 and DC54 and the number of iso-
leucines is reduced by about 0.7 units. The class one 
mutants show an increased amount of valine (DC1, 
DC13, DC19, DC24) and a reduced amount of iso-
leucine. For further analysis the proteolipids (4 mg 
Lowry protein) were cleaved with cyanogen bromide. 
The resulting peptides could be partially separated by 
chromatography on Bio-GeI P-30 in 80 % formic acid. 
Fig.3 shows a typical elution pattern obtained for all 
the proteins used in these experiments (wild type and 
mutants). The fragments are numbered according to 
their occurrence in the sequence (see Fig. 4). The large 
fragment B6 could be obtained in pure form, while 
peptides B7 and B8 as well as peptides B2, B3, B4 
and B9 are eluted together. These pep tides could be 
finally purified by preparative thin-layer chromatog-
raphy [16]. The individual mutant peptides and the 
corresponding wild type fragments exhibited the same 
RF-values. This is in contrast to the recently described 
protein of the uncB-type mutant DG7/1, where an 
alteration in peptide B7 could be detected by thin-layer 
chromatography [16]. Amino acid analysis of all the 
peptides was performed. No changes in amino acid 
content could be detected in the peptides B2, B3, B4, 
B7, B8 and B9 (data not shown). As these peptides 
are small, an amino acid exchange in these peptides 
should be detected by amino acid analysis. The amino 
acid analysis of the large fragment B6 is shown in 
Table 3. The data clearly show that peptides B6 from 
the mutants DC1, DCt3, DC19, DC24 contain an 
extra valine residue while one isoleucine is missing. 
The analysis of the B6 fragment from the mutant B25 
and DC54 suggest an isoleucine-threonine exchange. 
It should be noted that both exchanges can originate 
from a point mutation. The exchanged amino acid 
was localized by sequenching the whole protein and/ 
or the peptide B6. In all six mutants analysed, the 
amino acid exchange was found to be located at posi-
70 
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Table 2. Amino acid analysis of whole mutant and wild type proteolipid 
The values in parenthesis represent the number of amino acid residues obtained by sequence analysis. Hydrolysis was carried out for 
24, 48, 72 h. Methioninesulfone was determined after 24 h hydrolysis 
Amino acid 
Aspartic acid 
Methionine sulfone 
Threonine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Valine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Lysine 
Arginine 
~ 0.2 
o 
DJ 
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co 
"' .0 
~ 0.1 
« 
B6 
Amount in strain 
--- -- ------------
Al DCl 
mol/mol 
5.15 (5) 4.83 
7.7 (8) 7.01 
1.18 (1) 0.97 
4.13 (4) 4.26 
2.78 (3) 2.8 
9.0 (10) 9.6 
12.8 (13) 12.8 
5.4 (6) 5.6 
6.8 (8) 6.34 
11.8 (12) 11.2 
1.69 (2) 1.76 
3.76 (4) 3.8 
1.14 (1) 1.08 
2.16 (2) 1.9 
B8 B2.3.4.9 
B7 
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Fig.3. P30 gel chromatography of the cyanogen-hromide fragments 
of the dicyclohexylcarhodiimide-hinding protein from the mutant 
DC 13. 5 mg of protein were cleaved with CNBr. Pep tides were 
separated on a column 0.8 x 150 cm with P30 (minus-400 mesh) 
in 80% formic acid at a flow rate of 1.5 ml/h. Fractions of 750 III 
were collected. (--) absorbance at 280 nm. (- .... ) Refractive 
index 
tion 28 of the whole protein. The isoleucine residue 
located at this position in the wild type is exchanged 
by a valine residue in all class-one mutants. A threonine 
residue at this position is found in proteolipids from 
class two. Substitution by valine leads to a moderate 
resistance towards modification by dicyclohexyicarbo-
diimide, while a threonine results in a strong resistance. 
Interestingly, among the six mutants investigated in 
these studies only these two types of mutants could 
be detected. It can be stated that amino acid 28 is 
------- --
DC 13 DC19 DC24 DC25 DC54 
5.02 5.1 5.06 5.21 5.19 
7.4 7.84 7.5 7.02 7.46 
1.30 1.0 1.04 2.05 2.28 
4.23 4.4 4.3 4.1 4.1 
2.6 2.9 2.7 2.7 2.8 
9.33 9.6 9.7 9.57 9.44 
12.8 12.8 12.8 12.8 12.8 
6.2 6.0 6.0 5.4 5.65 
5.79 6.2 6.2 6.11 6.38 
11.7 11.9 11.9 11.95 11.8 
1.83 1.9 1.9 1.94 1.71 
3.84 3.80 3.9 3.85 3.78 
1.04 1.10 1.1 1.06 1.13 
1.88 1.96 1.99 1.88 1.96 
the only exchanged residue, since no other alterations 
were detected during sequence analysis of the whole 
protein which covered about two thirds of the entire 
sequence. No alteration in the remaining small C-
terminal peptides was found by thin-layer chromatog-
raphy and amino acid analysis. 
DISCUSSION 
In the present studies amino acid exchanges have 
been identified in the proteolipid subunit of the A TP 
synthase from Escherichia coli showing increased re-
sistance towards the inhibitor dicyclohexyicarbo-
diimide. Out of about 20 strains selected for inhibitor-
resistant growth [18]. six mutant strains showed in-
hibitor-resistant ATPase activity in vitro. All six 
mutants were found to be altered in the A TP synthase 
proteolipid subunit. Only two different mutant pro-
teolipids were detected, one containing an isoleucine-
valine exchange and the other an isoleucine-threonine 
exchange. Interestingly, in both cases the same iso-
leucine at position 28 of the amino acid sequence is 
substituted. 
Although only six mutants have been analysed the 
finding of just two different amino acid substitutions 
is unexpected, especially since only one position is 
affected, and since a point mutation in the isoleucine 
codons could lead to a variety of amino acid substitu-
tions in addition to the observed two exchanges. This 
suggest that besides the covalently modified aspartic 
acid 61 only the observed alterations influence the 
binding of the inhibitor. It is more reasonable to 
assume, however, that alterations of other residues 
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Table 3. Amino acid analysis of the large cyanogen-bromide fragment 8-6 
Hydrolysis was carried out for 24 and 72 h 
Amino acid 
Aspartic acid 
Threonine 
Homoserine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Valine 
Isoleucine 
Leucine 
Phenylalanine 
Lysine 
Arginine 
Amount in strain 
Al 
mol/mol 
1.0 (1) 
0.88 (1 ) 
0.90 (1) 
3.33 (3) 
1.78 (2) 
6.98 (7) 
6.02 (6) 
0.87 (1) 
5.74 (6) 
6.08 (6) 
2.88 (3) 
1.21 (1) 
1.88 (2) 
5 
DCl DC13 
1.05 1.0 
0.93 0.88 
0.99 0.91 
3.4 3.42 
1.76 1.8 
6.75 6.8 
6.02 6.02 
1.6 1.66 
4.4 4.65 
5.86 6.04 
2.83 2.88 
1.06 1.2 
1.93 1.9 
10 
DC19 DC24 DC25 DC54 
1.05 0.98 1.01 1.05 
0.98 0.88 1.83 1.75 
0.98 0.96 1.0 0.88 
3.45 3.3 3.4 3.44 
1.8 1.70 1.9 2.01 
7.02 6.8 7.0 6.85 
6.02 6.02 6.02 6.02 
1.8 1.76 0.84 0.73 
4.6 4.6 4.65 4.1 
6.14 5.9 5.9 6.03 
2.90 2.96 2.86 2.83 
1.09 0.87 1.3 1.22 
1.93 1.84 1.88 1.9 
15 20 
FMET-GLU-AsN-LEU-AsN-MET-Asp-LEU-LEU-TYR-MET-ALA-ALA-ALA-VAL-MET-MET-GLy-LEU-ALA-
B1.-- B2 .. -4- B3 . . B4 • B5 . 
25 THR 30 35 40 
ALA-ILE-GLy-ALA-ALA-ILE-GLy-ILE-GLy-ILE-LEu-GLy-GLy-LyS-PHE-LEu-GLu-GLy-ALA-ALA-
VAL 
B6 ---------------
45 50 55 60 
ARG-GLN-PRo-Asp-LEu-ILE-PRo-LEu-LEu-ARG-THR-GLN-PHE-PHE-ILE-VAL-r1ET-GLy-LEU-VAL-
65 70 75 
Asp-ALA-ILE-PRo-MET-ILE-ALA-VAL-GLy-LEu-GLy-LEu-TYR-VAL-MET-PHE-ALA-VAL-ALA 
- B7 ----.... B8 --------__ • _ B9 --
Fig. 4. Amino acid sequence of the dicyclohexylcarbodiimide-binding protein from wild type and mutants. Bl to B9 indicate the fragments 
produced by cyanogen bromide 
possibly involved in (cHxN)zC-binding lead to defects 
in the assembly or function of the proteolipid. It may 
be relevant in this respect that the isoleucine 28 occurs 
in a glycine-rich segment (see Fig.4) of the proteolipid 
sequence which appears to be highly conserved when 
the proteolipid species from phylogenetically distant 
organisms are compared [12,13]. In the mitochondrial 
proteolipid species also an isoleucine is present at the 
corresponding position. While the (cHxNhC-sensi-
tivity of the Neurospora ATPase is comparable to that 
of E. coli, the beef heart enzyme is much more sensitive 
[4]. On the other hand the ATPase from thermophilic 
bacterium PS-3 [14] exhibiting a sensitivity compa-
rable to E. coli contains an asparagine at the corre-
sponding position of the proteolipid subunit. Hyper-
sensitivity to (cHxNhC was observed in three types 
of oligomycin-resistant mutants from Neurospora (Se-
bald, W., unpublised observations), containing amino 
acid substitutions in the ATPase proteolipid in close 
vicinity to the (cHxNhC-binding glutamyl residue. 
Thus, the isoleucine 28 is apparently only one of 
several residues determining the sensitivity towards the 
inhibitor. 
The two amino acid exchanges observed in the 
(cHxNhC-resistant E. coli mutants are inconspicuous. 
The amino acids isoleucine and valine have a similarly 
low polarity, whereas threonine has a polar uncharged 
side chain~: This may be correlated with the observation 
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that the valine-containing mutants exhibit moderate 
resistance and the threonine-containing mutants high 
resistance towards (cHxNhC. The side chains of both 
the valine and the threonine are slightly smaller than 
that of the isoleucine. A larger hydrophobic surface 
possibly supports the binding of the cyclohexyl group 
of the inhibitor. 
Remarkable, the residue 28 altered in the mutants 
is located in the primary structure 33 residues away 
from aspartic acid at residue 61, to which dicyclo-
hexylcarbodiimide binds covalently, most likely by 
forming the stable N-acylurea [15]. Nevertheless, the 
changed residues found at position 28 specifically 
reduce the binding affinity of the proteolipid for the 
inhibitor. At increased concentration the inhibitor still 
binds to aspartic acid 61, and thereby inhibits ATP 
synthase activities. Functional properties of the A TP 
synthase appear to be unchanged in the mutants as 
deduced from the unaltered levels of ATPase activity 
and A TP-dependent H + -translocation. Considering 
further the conservative amino acid substitutions in 
the class-one mutants, an allosteric effect on the 
binding of (cHxN)zC appears unlikely. Thus, it is 
proposed that the isoleucine residue 28 forms part of 
the binding site for the inhibitor. This provides a first, 
but admittedly indirect, indication, that the poly-
peptide chain folds back to juxtapose isoleucine 28 
and aspartic acid 61 in the functional conformation 
of the proteolipid. The situation may be more com-
plicated, however, since the proteolipid occurs in the 
ATP synthase as oligomer [1,4,8], and the binding 
site for (cHxNhC may be provided by different mono-
mers. It will be interesting to see in future experi-
ments whether isolated monomeric mutant proteo-
lipids retain their decreased affinity for the inhibitor. 
The amino acid sequences of the dicyclohexyl-
carbodiimide-binding proteolipid from all organisms 
analysed up to now show a clustering of hydrophobic 
and hydrophilic amino acid residues [12-14]. Gener-
ally, hydrophobic segments of about 25 residues are 
interrupted by a polar segment of 12 to 20 residues. 
This is reminiscent to bacteriorhodopsin from Halo-
hacterium halohium [31-33]. The hydrophobic seg-
ments may traverse the membrane in an a-helical con-
formation, whereas the polar loop may be either ex-
posed to the water phase or may be in contact with 
other subunits of the ATP synthase complex. The 
above proposal that isoleucine 28 and aspartic acid 61 
are in close proximity would fit excellen1ly to such a 
'hair pin' model. 
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